Anti-inflammatory Strategy in Acute Myocarditis — No Benefit Anti-inflammatory Strategy in Acute Myocarditis — No Benefit

A short course of the interleukin-1 receptor antagonist, anakinra, appeared safe but did not reduce complications of acute myocarditis in the ARAMIS trial.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Cardiology News Source Type: news